Lower Blood Pressure May Offer Benefits Even for the Very Elderly

Adults aged 80 and older experience the highest prevalence of cardiovascular disease, yet the optimal blood pressure targets for this group have been unclear in clinical guidelines. Now, a new study from Yale School of Medicine (YSM) suggests that intensive blood pressure management may offer important benefits for very elderly patients. As the American population … Read more

Arthritis Precedes Psoriasis More Often Than Expected

Hannah Y. Gantz Credit: Linkedin New research has found that symptoms of psoriatic arthritis (PsA) often precede psoriasis (PsO) development and psoriasis skin lesions.1 “PsA occurs in about 30% of patients with PsO, and an additional 5%–15% of psoriasis patients may have undiagnosed PsA. The current dogma is that PsO skin lesions generally occur before … Read more

Can Endocrine NP Training Help Ease Provider Shortage?

ORLANDO, Fla. — A program at Duke University School of Nursing, Durham, North Carolina, is currently one of just two in the United States that trains nurse practitioners (NPs) to provide endocrine specialty care, but more could be on the way. Established in 2016, the program was “a result of national demand for diabetes and … Read more

LAP May Predict Risk of Hyperuricemia and Gout

Lipid accumulation product had high potential in predicting the risk of gout/hyperuricemia in new research, offering a potentially modifiable risk factor for preventing gout.1 “Traditional metrics for evaluating obesity, such as Body Mass Index (BMI) and Waist Circumference (WC), have been widely utilized; however, they exhibit significant limitations in accurately reflecting the complex nature of … Read more

OCT Features May Signal Risk of Retinal Atrophy, Study Suggests

Image Credit: Adobe Stock A recent study from Sapienza University of Rome has indicated that optical coherence tomography (OCT) features such as type 2 macular neovascularization (MNV), reductions in outer nuclear layer (ONL) and central foveal thickness (CFT), and intraretinal fluid (IRF) presence at baseline could signal higher risks of retinal atrophy (RA) in treatment-naïve … Read more

Recognizing Actinic Keratosis, Cancer Risk, with Elizabeth Hale, MD

Actinic keratosis represents one of modern healthcare’s most overlooked and dangerous skin conditions. With global prevalence estimates of 14% and higher rates observed in older populations and those with significant UV exposure, the precancerous condition poses a significant risk to long-term health when left untreated or undiagnosed.1 “It’s really important that not just dermatologists, but … Read more

Triamcinolone Acetonide May Prevent Postoperative Diabetic Macular Edema

A recent retrospective study from Zhejiang, China has indicated that triamcinolone acetonide (TA) injections may successfully prevent the onset of diabetic macular edema (DME) after pars plana vitrectomy (PPV), a common postoperative complication in patients with proliferative diabetic retinopathy (PDR).1 Macular edema is a very common complication with many ocular diseases; it manifests as accumulation … Read more

Semaglutide Protects Against Osteoporosis, Gout, in People With Obesity and Type 2 Diabetes

Semaglutide demonstrated notable protective effects on osteoporosis and gout in people with obesity and type 2 diabetes (T2D) in a new cohort study.1 “The impact of newer anti-obesity medications on skeletal health remains incompletely understood, particularly in populations with varying metabolic profiles,” lead investigator Jo-Ching Chen, Chung Shan Medical University Hospital, Taichung, Taiwan, and colleagues … Read more

Long-term antidepressant use linked to higher risk of withdrawal symptoms

People who have been taking antidepressants for more than two years are substantially more likely to experience withdrawal symptoms compared to short-term users when they come off the medication, finds a new study led by UCL researchers. Long-term users also tend to experience worse withdrawal symptoms, and for a longer period of time, than short-term … Read more

Belimumab Superior to Placebo in Yielding Systemic Lupus Erythematosus Responses

Ioannis Parodis, MD, PhD Credit: Research Gate A new meta-analysis has found that belimumab was superior to placebo according to BICLA criteria in patients with systemic lupus erythematosus (SLE).1 “The results from this post hoc analysis of foundational phase III SLE belimumab trials have important implications for clinical practice, as they substantiate the clinical efficacy … Read more